{"id":624766,"title":"Consultation Notice: Health Canada Requests Feedback on Potential Impacts and Uses if Company Names were added to the Generic Submissions Under Review List - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T05:11:24.788000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/notice-company-names-generic-submissions-under-review.html","snippet":"Consultation Notice: Health Canada Requests Feedback on Potential Impacts and Uses if Company Names were added to the Generic Submissions Under Review List January 7, 2019 Our file number: 18-121970-181 As a regulator, Health Canada plays an important role in protecting the…","rawSnapshotUrl":"/api/snapshots/raw/624766","browseUrl":"https://replay.healtharchive.ca/job-6/20260227051124/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/notice-company-names-generic-submissions-under-review.html#ha_snapshot=624766","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}